SCHEMBL6902689

SCHEMBL6902689

CC1(Br)C=CC=CC1C(=O)Cl

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL744087 0.82
Bicarbonate SCHEMBL20918166 0.80
SCHEMBL4976486 0.78
SCHEMBL23648250 0.77 ALDH1A1 (0.30)
SCHEMBL28412593 0.76
SCHEMBL8819008 0.76
SCHEMBL5787196 0.76
SCHEMBL486744 0.74 MAPK1 (0.34)
SCHEMBL2555079 0.72
SCHEMBL9662041 0.71

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1385856-A2 AMINO ACID COMPLEXES OF C-ARYL GLUCOSIDES FOR TREATMENT OF DIABETES AND METHOD Bristol-Myers Squibb Company (US) 2004-02-04 EP disclosed
WO-2002083066-A2 AMINO ACID COMPLEXES OF C-ARYL GLUCOSIDES FOR TREATMENT OF DIABETES AND METHOD BRISTOL-MYERS SQUIBB COMPANY (US) 2002-10-24 WO disclosed